Back to Search
GRAHAM EMSLIE, MD
MD
Child & Adolescent Psychiatry Physician
NPI: 1114989191Individual
Specialties, Licenses & Credentials
Child & Adolescent Psychiatry PhysicianPrimary
Psychiatry & Neurology — Child & Adolescent Psychiatry
Code: 2084P0804X
G0999(TX)
Research & Publications (20)
Combination of cognitive behavioral therapy and sertraline is more effective than monotherapy for pediatric anxiety disorders.
PMID 19364568·J Pediatr·2009
8-other
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
PMID 19182688·J Am Acad Child Adolesc Psychiatry·2009
4-observational
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.
PMID 18281410·Am J Psychiatry·2008
4-observational
A psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children.
PMID 17712244·J Am Acad Child Adolesc Psychiatry·2007
2-rct
Antidepressant management in the context of suicidal ideation.
PMID 17712247·J Am Acad Child Adolesc Psychiatry·2007
5-case
Long-term, open-label venlafaxine extended-release treatment in children and adolescents with major depressive disorder.
PMID 17329983·CNS Spectr·2007
3-trial
Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.
PMID 17420682·J Am Acad Child Adolesc Psychiatry·2007
4-observational
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.
PMID 17513980·J Am Acad Child Adolesc Psychiatry·2007
8-other
Treatment for Adolescents with Depression Study (TADS): safety results.
PMID 17135989·J Am Acad Child Adolesc Psychiatry·2006
2-rct
Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government.
PMID 16540810·J Am Acad Child Adolesc Psychiatry·2006
8-other
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.
PMID 16721314·J Am Acad Child Adolesc Psychiatry·2006
8-other
Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.
PMID 16721321·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
PMID 16124837·J Clin Psychiatry·2005
6-review
Continuation and maintenance therapy of early-onset major depressive disorder.
PMID 16117558·Paediatr Drugs·2005
6-review
Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.
PMID 15502599·J Am Acad Child Adolesc Psychiatry·2004
3-trial
A feasibility study of the childhood depression medication algorithm: the Texas Children's Medication Algorithm Project (CMAP).
PMID 15100558·J Am Acad Child Adolesc Psychiatry·2004
3-trial
Predictors of response to treatment in children and adolescents with mood disorders.
PMID 12778842·Psychiatr Clin North Am·2003
6-review
Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.
PMID 12364842·J Am Acad Child Adolesc Psychiatry·2002
3-trial
Mood disorders in children and adolescents: psychopharmacological treatment.
PMID 11430850·Biol Psychiatry·2001
8-other
Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder.
PMID 11466166·Int J Neuropsychopharmacol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5323 HARRY HINES BLVD
DALLAS, TX 75390 - Phone
- (214) 645-5900
Quick Facts
- NPI
- 1114989191
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile